ASRT250919C00002000 Option on Assertio Therapeutics

An 'Out of The Money' option on Assertio has a strike price that Assertio Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Assertio Therapeutics' 'Out of The Money' options include buying the options if you expect a big move in Assertio Therapeutics' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Assertio Therapeutics' Option Greeks for the contract ending on 2025-09-19 at a strike price of 2.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Assertio Therapeutics' option greeks, its implied volatility helps estimate the risk of Assertio Therapeutics stock implied by the prices of the options on Assertio Therapeutics' stock.

Put options written on Assertio Therapeutics grant holders of the option the right to sell a specified amount of Assertio Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Assertio Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Assertio Therapeutics is like buying insurance aginst Assertio Therapeutics' downside shift.

By selling Assertio Therapeutics' put option, the investors signal their bearish sentiment. A short position in a put option written on Assertio Therapeutics will generally make money when the underlying price is above the strike price. Therefore Assertio Therapeutics' put payoff at expiration depends on where the Assertio Stock price is relative to the put option strike price. The breakeven price of 2.03 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Assertio Therapeutics' price. Finally, at the strike price of 2.0, the payoff chart is constant and positive.

Assertio Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Assertio. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Assertio. It also shows strike prices and maturity days for a Assertio Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.